Indian Indices
20,969.40 68.25
69,825.60 303.91
( 0.44%)
Bank Nifty
47,262.00 420.60
( 0.90%)
Nifty IT
33,392.90 431.30
( 1.31%)
Global Indices
14,403.97 63.98
Dow Jones
36,247.87 130.49
Hang Seng
16,334.37 -11.52
Nikkei 225
32,307.86 -550.45
83.35 0.02
89.85 -0.03
104.79 -0.12
0.57 0.01

IPO Synopsis

  • HOME breadcrum-arrow
  • IPO Synopsis


Laxmi Organic Industries Ltd
  • Registered Office: A-22/2/3 MIDC,Mahad, Raigad - 402309, Maharashtra, India. Phone : 91-2145-232424   Fax:
  • Email : investors@laxmi.com
  • Website :www.laxmi.com
Initial public offering of 46,153,846 equity shares of face value of Rs. 2 each ("equity shares") of Laxmi Organic Industries Limited ("The Company" or The "Issuer") for cash at a price of Rs. 130 per equity share (Including a premium of Rs. 128 per equity share) ("offer price") aggregating to Rs. 600.00 crore ("offer"). The offer comprises of a fresh issue of 23,076,923 equity shares aggregating to Rs. 300.00 crores ("Fresh issue") and an offer for sale of 23,076,923 equity shares aggregating to Rs. 300.00 crores by Yellow Stone Trust ("promoter selling shareholder"), (The "offer for sale", and together with the fresh issue, the "offer"). The offer will constitute 17.50% of the post-offer paid-up equity share capital. The face value of equity shares is Rs.2 each and Offer Price is 130 of the face value of the equity share. The Issue Price is 65.00 times of the face value.
Opens On Closes On
15-Mar-21 17-Mar-21
Money Payable On
Application Allotment
130.00 0.00
Minimum Application for shares in Nos : 115 Further Multiples of : 115
Cr Lead Managers to the Issue
Project Cost (.Cr) 500.00 Axis Capital Ltd
Project Financed through Current Offer (.Cr) 600.00  
Post Issue Equity Share Capital (.Cr) 52.73
Issue Price () 130.00
Investment in wholly owned subsidiary, Yellowstone Fine Chemicals Private Limited ("YFCPL") for part-financing its capital expenditure requirements in relation to the setting up of manufacturing facility for fluorospecialty Chemicals("Proposed")
Investment in YFCPL for funding its working capital requirements
Funding capital expenditure requirements for expansion of SI Manufacturing Facility ("Proposed Expansion")
Funding working capital requirements of the company
Purchase of plant and machinery for augmenting infrastructure development at SI Manufacturing Facility
Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and wholly owned subsidiary, Viva Lifesciences Private Limited ("VLPL")
General corporate purposes
Promoted By
Yellow Stone Trust
Ravi Goenka
Listing At
Registrar to the Issue
No Data Available